FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

PACK Pharmaceuticals Timolol Maleate Sterile Ophthalmic Solution Recall

Timolol Maleate Sterile Ophthalmic Solution, USP 0

PACK Pharmaceuticals, LLC · Buffalo Grove, IL

Risk level
Class III
Reported by FDA
Feb 12, 2014
Recall ID
D-1070-2014
Check your lot numberHow we source this data

Summary

PACK Pharmaceuticals recalled Timolol Maleate Sterile Ophthalmic Solution starting Sep 9, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1070-2014 on Feb 12, 2014. Reason: Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles. Status: Terminated.

Why it was recalled

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Product description

Timolol Maleate Sterile Ophthalmic Solution, USP 0.25%, 5mL, (NDC 16571-140-50). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.

Lot numbers, UPCs & expiration codes

Lot #: NW3061,NW3062. Exp. 05/15.

Where it was sold

Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1070-2014
Classification
Class III
Status
Terminated
Recall initiated
Sep 9, 2013
FDA report date
Feb 12, 2014
Quantity
3,415 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
PACK Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-1070-2014, exactly as published.

Show all FDA fields
City
Buffalo Grove
State
IL
Status
Terminated
Country
United States
Event ID
66595
Address
1110 W Lake Cook Rd
Address (line 2)
Ste 301
Code information
Lot #: NW3061,NW3062. Exp. 05/15.
Postal code
60089-1944
Report date
Feb 12, 2014
Product type
Drugs
Recall number
D-1070-2014
Classification
Class III
Recalling firm
PACK Pharmaceuticals, LLC
Product quantity
3,415 bottles
Termination date
Apr 11, 2014
Reason for recall
Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Timolol Maleate Sterile Ophthalmic Solution, USP 0.25%, 5mL, (NDC 16571-140-50). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.
Distribution pattern
Nationwide and Puerto Rico.
Recall initiation date
Sep 9, 2013
Initial firm notification
Letter
Center classification date
Feb 4, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1070-2014, published Feb 12, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls